Ronald C. Renaud JR

Insider Reports History

Entity
Individual
Location
C/O Idenix Pharmaceuticals, Inc., 60 Hampshire Street, Cambridge, MA
Signature
/s/ Michael Gray, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ronald C. Renaud JR:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Atara Biotherapeutics, Inc. Director Common Stock 31.5K $12.3K $0.39 Jun 23, 2022 Direct
Cerevel Therapeutics Holdings, Inc. President & CEO, Director Common Stock 0 $0 $41.18 Aug 1, 2024 By Trust
Cerevel Therapeutics Holdings, Inc. President & CEO, Director Common Stock 0 $0 $41.18 Aug 1, 2024 Direct
Cerevel Therapeutics Holdings, Inc. President & CEO, Director Performance-based Restricted Stock Units 0 $0 $41.18 Aug 1, 2024 Direct
Cerevel Therapeutics Holdings, Inc. President & CEO, Director Restricted Stock Units 0 $0 $41.18 Aug 1, 2024 Direct
Atara Biotherapeutics, Inc. Director Non-Qualified Stock Option (Right to Buy) 31.5K Jun 23, 2022 Direct
Upstream Bio, Inc. Director Stock Option (Right to Buy) 17.1K Oct 10, 2024 Direct
Ikena Oncology, Inc. Director Stock Option (Right to Buy) 13.4K Jun 9, 2022 Direct
Cerevel Therapeutics Holdings, Inc. President & CEO, Director Stock Option (Right to Buy) 0 Aug 1, 2024 Direct
Translate Bio, Inc. Chief Executive Officer, Director Common Stock 0 $38.00 Sep 14, 2021 By Ronald C. Renaud, Jr. Trust - 2007
Translate Bio, Inc. Chief Executive Officer, Director Common Stock 0 $38.00 Sep 14, 2021 By Ronald Renaud 2014 Irrevocable Family Trust
Translate Bio, Inc. Chief Executive Officer, Director Common Stock 0 $38.00 Sep 14, 2021 Direct
Translate Bio, Inc. Chief Executive Officer, Director Stcok Option (right to buy) 0 Sep 14, 2021 Direct
Translate Bio, Inc. Chief Executive Officer, Director Stock Option (right to buy) 0 Sep 14, 2021 Direct

Insider Reports Filed by Ronald C. Renaud JR

Symbol Company Period Transactions Value $ Form Type Date Filed Role
UPB Upstream Bio, Inc. Oct 10, 2024 1 $0 4 Oct 15, 2024 Director
UPB Upstream Bio, Inc. Oct 10, 2024 0 $0 3 Oct 10, 2024 Director
CERE Cerevel Therapeutics Holdings, Inc. Aug 1, 2024 5 $0 4 Aug 5, 2024 President & CEO, Director
CERE Cerevel Therapeutics Holdings, Inc. Jan 19, 2024 1 $0 4 Jan 23, 2024 President & CEO, Director
CERE Cerevel Therapeutics Holdings, Inc. Dec 19, 2023 2 $0 4 Dec 21, 2023 President & CEO, Director
CERE Cerevel Therapeutics Holdings, Inc. Aug 3, 2023 1 $2.01M 4 Aug 7, 2023 President & CEO, Director
CERE Cerevel Therapeutics Holdings, Inc. Jun 12, 2023 3 $0 4 Jun 14, 2023 President & CEO, Director
CERE Cerevel Therapeutics Holdings, Inc. Jun 12, 2023 0 $0 3 Jun 14, 2023 President & CEO, Director
ATRA Atara Biotherapeutics, Inc. Jun 23, 2022 2 $0 4 Jun 27, 2022 Director
IKNA Ikena Oncology, Inc. Jun 9, 2022 1 $0 4 Jun 13, 2022 Director
IKNA Ikena Oncology, Inc. Dec 21, 2021 1 $0 4 Dec 23, 2021 Director
TBIO Translate Bio, Inc. Sep 14, 2021 8 -$36.3M 4 Sep 14, 2021 Chief Executive Officer, Director
ATRA Atara Biotherapeutics, Inc. Jun 8, 2021 2 $0 4 Jun 9, 2021 Director
TBIO Translate Bio, Inc. Apr 7, 2021 2 $66.7K 4/A Sep 14, 2021 Chief Executive Officer, Director